A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development

[1]  P. C. van de Kerkhof,et al.  Are Newly Discovered Drivers of Immune-Mediated Skin Disorders Expressed in Normal Skin Regenerating from Standardized Surface Injury? , 2014, Dermatology.

[2]  Amitava Das,et al.  Engulfment of Apoptotic Cells by Macrophages: A Role of MicroRNA-21 in the Resolution of Wound Inflammation , 2014, The Journal of Immunology.

[3]  T. Elton,et al.  Regulation of the MIR155 host gene in physiological and pathological processes. , 2013, Gene.

[4]  S. Pfeffer,et al.  The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid Arthritis , 2013, Front. Immunol..

[5]  Zhongmin Liu,et al.  MicroRNA-7–regulated TLR9 signaling–enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway , 2013, Molecular biology of the cell.

[6]  Zhongmin Liu,et al.  MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer , 2012, PloS one.

[7]  Jianni Qi,et al.  microRNA‐210 negatively regulates LPS‐induced production of proinflammatory cytokines by targeting NF‐κB1 in murine macrophages , 2012, FEBS letters.

[8]  M. Chan,et al.  Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. , 2011, The American Journal of dermatopathology.

[9]  Andrew Johnston,et al.  Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis , 2011, PloS one.

[10]  R. Coffman,et al.  Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 , 2010, The Journal of experimental medicine.

[11]  Gang Wang,et al.  Serum and Urinary Cell–free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.

[12]  H. Dickel,et al.  Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL‐33, TNF‐α and IL‐8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’ , 2010, Contact dermatitis.

[13]  Yuanjia Tang,et al.  MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.

[14]  Frances Gotch,et al.  miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.

[15]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[16]  Michael T. McManus,et al.  LPS induces KH‐type splicing regulatory protein‐dependent processing of microRNA‐155 precursors in macrophages , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  D. Iliopoulos,et al.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.

[18]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[19]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[20]  Michael Detmar,et al.  Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[21]  M. Schön,et al.  Imiquimod: mode of action , 2007, The British journal of dermatology.

[22]  Lars Karlsson,et al.  TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. , 2007, Inflammation & allergy drug targets.

[23]  J. Wenzel,et al.  Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches , 2007, Experimental dermatology.

[24]  D. Marks,et al.  Modified skin window technique for the extended characterisation of acute inflammation in humans , 2007, Inflammation Research.

[25]  T. Bieber,et al.  Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus , 2005, The Journal of pathology.

[26]  G. Stingl,et al.  Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod1 , 2004, The Journal of Immunology.

[27]  Byun,et al.  Patients with Systemic Lupus Erythematosus , 1999 .

[28]  B. Nickoloff,et al.  Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. , 1994, Journal of the American Academy of Dermatology.

[29]  P. Elias,et al.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.

[30]  J. Streilein,et al.  Depletion of epidermal langerhans cells and Ia immunogenicity from tape- stripped mouse skin , 1982, The Journal of experimental medicine.